These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30548936)

  • 1. Development of an HIV-1 integrase genotyping assay for HIV-1 subtype AE.
    Liu Y; Margot N; Kitrinos KM; Callebaut C
    J Med Virol; 2019 May; 91(5):890-893. PubMed ID: 30548936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
    Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
    J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
    To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
    J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV-1 integrase genotype assay for the detection of drug resistance mutations.
    Hearps AC; Greengrass V; Hoy J; Crowe SM
    Sex Health; 2009 Dec; 6(4):305-9. PubMed ID: 19917199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
    Armenia D; Fabeni L; Alteri C; Di Pinto D; Di Carlo D; Bertoli A; Gori C; Carta S; Fedele V; Forbici F; D'Arrigo R; Svicher V; Berno G; Pizzi D; Nicastri E; Sarmati L; Pinnetti C; Ammassari A; D'Offizi G; Latini A; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM
    J Antimicrob Chemother; 2015; 70(6):1865-73. PubMed ID: 25712318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients.
    Isarangkura-Na-Ayuthaya P; Kaewnoo W; Auwanit W; de Silva UC; Ikuta K; Sawanpanyalert P; Kameoka M
    AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1341-3. PubMed ID: 20836708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
    Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
    Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.
    Ammaranond P; Sanguansittianant S; Raju PA; Cunningham P; Horthongkham N
    J Virol Methods; 2014 Apr; 199():102-7. PubMed ID: 24462843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.
    Van den Eede P; Van Wesenbeeck L; Verlinden Y; Feyaerts M; Smits V; Verheyen A; Vanhooren L; Deloof A; Villacian J; Pattery T
    Methods Mol Biol; 2013; 1030():37-55. PubMed ID: 23821259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective tool for identifying HIV-1 subtypes B, C, CRF01_AE, their recombinant forms, and dual infections in Southeast Asia by the multi-region subtype specific PCR (MSSP) assay.
    Sakkhachornphop S; Kijak GH; Beyrer C; Razak MH; Sanders-Buell E; Jittiwutikarn J; Suriyanon V; Robb ML; Kim JH; Celentano DD; McCutchan FE; Tovanabutra S
    J Virol Methods; 2015 Jun; 217():70-8. PubMed ID: 25725414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
    Moore HP; Palumbo PJ; Notarte KI; Fogel JM; Cummings V; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Remien RH; Beyrer C; Hudelson SE; Eshleman SH;
    J Clin Microbiol; 2024 Jun; 62(6):e0013624. PubMed ID: 38727213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of HIV-1 subtype B, CRF01_AE, CRF33_01B, and newly emerging recombinant lineages in Malaysia.
    Chook JB; Ong LY; Takebe Y; Chan KG; Choo M; Kamarulzaman A; Tee KK
    Am J Trop Med Hyg; 2015 Mar; 92(3):507-512. PubMed ID: 25535315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
    Brenner BG; Lowe M; Moisi D; Hardy I; Gagnon S; Charest H; Baril JG; Wainberg MA; Roger M
    J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust and sensitive subtype-generic HIV-1 pol genotyping for use with dried serum spots in epidemiological studies.
    Hauser A; Meixenberger K; Machnowska P; Fiedler S; Hanke K; Hofmann A; Bartmeyer B; Bremer V; Bannert N; Kuecherer C
    J Virol Methods; 2018 Sep; 259():32-38. PubMed ID: 29859195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
    Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
    J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
    Van Laethem K; Schrooten Y; Covens K; Dekeersmaeker N; De Munter P; Van Wijngaerden E; Van Ranst M; Vandamme AM
    J Virol Methods; 2008 Nov; 153(2):176-81. PubMed ID: 18706932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries.
    Lapovok I; Laga V; Kazennova E; Bobkova M
    Curr HIV Res; 2017 Nov; 15(5):318-326. PubMed ID: 28814231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.